Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Active Not Recruiting NCT06279221

Litfulo Capsules Special Investigation

Conditions: Alopecia Areata

Sex: All
Ages: 0 Years – N/A
Healthy volunteers: No
Enrollment: 664
Sponsor: Pfizer

Location: Pfizer Tokyo

Summary

The objective of this Study is to confirm the safety during the long-term use of this drug and the effectiveness during the use of this drug under the actual use in the patients treated with this drug.

Eligibility Criteria

Inclusion Criteria: Patients must meet all of the following inclusion criteria to be eligible for inclusion in the study: * Patients with alopecia areata who start receiving this drug for the first time after the contract date of this study * Patients who have not participated in a clinical trial (clinical study) of this drug Exclusion Criteria: Patients meeting any of the following criteria will not be included in the study: * Patients previously enrolled in this study * Patients with a history of treatment with this drug (including investigational product)

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06279221). StuddyBuddy aggregates publicly available trial information.